Charles River Laboratories International Inc 2021 SR
The report highlights Charles River Laboratories' 75th anniversary and its role in supporting over 85% of FDA-approved drugs in 2021, including all approved COVID-19 vaccines. Key environmental achievements include a 25% reduction in Scope 1 and 2 emissions since 2018 and the signing of virtual Power Purchase Agreements to reach 100% renewable electricity by 2023. The company completed a comprehensive ESG materiality assessment and established an ESG Governance Council. Socially, it launched seven Employee Resource Groups and increased U.S. workforce diversity to 29%.
Company: Charles River Laboratories International Inc
Sector: Professional & technical services
Country: United States
Year: 2021
Type: SR
Pages: 64
Back to company
Charles River Laboratories International Inc
Corporate Citizenship Report
The report highlights Charles River Laboratories' 75th anniversary and its role in supporting over 85% of FDA-approved drugs in 2021, including all approved COVID-19 vaccines. Key environmental achievements include a 25% reduction in Scope 1 and 2 emissions since 2018 and the signing of virtual Power Purchase Agreements to reach 100% renewable electricity by 2023. The company completed a comprehensive ESG materiality assessment and established an ESG Governance Council. Socially, it launched seven Employee Resource Groups and increased U.S. workforce diversity to 29%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Women on Board
Women in Management
Workplace Fatalities
Employees